ABSTRACT Forty-one infants and children with the combination of patent ductus arteriosus (PDA) and ventricular septal defect (VSD) were encountered over 20 years. Twenty-four presented in infancy with congestive cardiac failure. Pulmonary hypertension was present in 32, the cause in 19 being increased pulmonary blood flow. Increased pulmonary vascular resistance (PVR) was detected in 13 (indicated by a pulmonary to systemic resistance ratio (Rp : RS) >0 24 1 and PVR>4 units). Thus 22% had a pulmonary artery systolic pressure less than 30 mmHg and 68% had a pulmonary vascular resistance below four units, indicating an unusually mild form of the combined condition in these patients. Surgical management is discussed, and in particular the question of simultaneous closure of the defects during infancy. Cardiac failure, resistant to drug treatment, and increased PVR are indications of operation. The PDA should be closed and only if there is no substantial fall in pulmonary artery pressure is the VSD repaired.
Although both ventricular septal defect (VSD) and patent ductus arteriosus (PDA) are common congenital cardiac anomalies occurring singly, the two combined are relatively uncommon (Hallman et al, 1964; Cartmill et al, 1966; Keith et al, 1978) .
Because of the existence of two separate systemic-pulmonary arterial shunts, pulmonary hypertension would be expected as a common accompaniment and congestive cardiac failure a common presentation in infancy. We present our experience with this combination of defects in 41 infants and children, most of whom were under the age of 2 years.
Patients and methods
During 1959-78 41 infants and children presented with the combination of PDA and VSD. Patients with additional anomalies (atrial septal defect, coarctation of aorta, and aortic stenosis) were excluded. Thirty-two patients were female and nine male, the age at presentation ranging from 1 month to 11 years (mean 19-7 Pulmonary vascular disease in association with VSD has been well documented (Hallman et al, 1964; Lillehei et al, 1964; Cartmill et al, 1966; Hallidie-Smith et al, 1969) . Although the condition can only be diagnosed with certainty on histological grounds (Heath and Edwards, 1958) , useful parameters based on haemodynamic data can be used to predict the presence or absence of pulmonary vascular disease. Kirklin (1965) Yasui et al (1977) found that simply relating the peak systolic pulmonary artery pressure to the peak systolic systemic pressure (Pp: Ps) was of great practical value in determining the need for surgical treatment in a group of 87 children under the age of 5 years. A ratio of 0-8: 1 was an indication for early operation to prevent the development of pulmonary vascular disease, but below this figure infants could safely be left until their first birthday. If at reinvestigation the haemodynamic picture had not improved, operation was then carried out.
For many years the recommended procedure for infants with intractable cardiac failure associated with a large VSD with pulmonary hypertension was pulmonary artery banding, followed in later childhood by repair of the defect and pulmonary artery reconstruction (Muller and Damman, 1952; Hallman et al, 1966; Reid et al, 1968; Stark et al, 1969; Coleman et al, 1972) . This procedure has now been superseded in large measure by primary repair of the defect in infancy when indicated (Cartmill et al, 1966; Yasui et al, 1977; Fox et al, 1978) .
The management of infants and young children with pulmonary hypertension accompanying the combined lesions of VSD and PDA is not so clear. Whether both lesions require immediate surgical treatment in infancy, or whether operation can be safely deferred till later childhood when the VSD may have undergone spontaneous closure or natural reduction in size and the PDA may have closed is still controversial. In nine of our patients spontaneous closure of the VSD was observed, and in a further 13 natural reduction in size occurred. Goor and Lillehei (1975) , while recognising that both lesions are best corrected at a single operation, recommended that in a sick infant with congestive heart failure PDA closure alone was preferable, particularly when the shunt through the PDA was large and that through the VSD was small.
We have attempted to arrive at a satisfactory management policy by analysing our experience in 41 children during a 19-year period. Our policy was to catheterise all who had developed congestive cardiac failure, and to proceed with operation either when there was evidence of serious pulmonary hypertension or when there was failure to thrive. Closure of the PDA was performed and if the pulmonary artery pressure dropped significantly nothing else was done. If the pressure remained high pulmonary artery banding was then performed to be superseded in recent years by repair of the defect as the method of choice. Clearly surgical treatment is not necessary in all patients with VSD and PDA and accompanying pulmonary hypertension during the first year of life. Although in our experience closure of the PDA alone carried no mortality, repair of the VSD certainly did. Cartmill et al (1966) had a mortality of 5% when surgical repair of a VSD was carried out in infancy. More recently Fox et al (1978) have recorded a fall in mortality to 1P9%, but they did not equate the risk of operation with the presence or absence of pulmonary vascular disease. The almost imponderable balance of risks is between that of operation and that of the development of pulmonary vascular obstruction. Clearly operation should not be deferred too long if PVR is raised and appears to be progressing at repeated catheter studies. Pulmonary vascular disease may be capable of regressing completely up to the age of 2 years if the causal defect or defects are repaired (Lillehei et al, 1964) , but if operation is left until after childhood this is less likely to take place (Lynfield et al, 1961; Hallidie-Smith et al, 1969 . One of our patients (case 3) was found to have pulmonary hypertension with a PVR of four units and Rp: Rs ratio of 025: 1 at the age of 5 months. Operation was deferred as the infant was thriving and the pulmonary blood flow was high (Qp: Qs 3-8: 1). She did not return for critical review until the age of 4 years when catheter studies indicated that pulmonary vascular obstruction had developed. Although the PDA and VSD were then repaired, the pulmonary artery pressure did not fall immediately, and the outlook is viewed with concern.
We would conclude that congestive cardiac failure in infancy is an indication for early investigation. If cardiac catheterisation confirms the presence of a large left to right shunt accompanied by pulmonary hypertension, early operation is necessary. The PDA should be closed, and only if there is no substantial fall in pulmonary artery pressure is the VSD repaired. Investigation should be repeated at or around the first birthday in those in whom the VSD was not repaired and in any others in whom operation was deferred. The presence of persistent pulmonary hypertension or early pulmonary vascular disease (indicated by an Rp: Rs>025: 1 or PVR>4 units) makes early repair of the residual defect or defects obligatory to prevent the development of permanent structural changes in the pulmonary vasculature. Clearly the management of this double defect must be kept under review, the critical features in the argument being the mortality of VSD repair in larger series than have been published to date, particularly in relation to infants with increased pulmonary vascular resistance, and improved understanding of the risk of irreversible pulmonary vascular disease inherent in the natural history of the condition. Although the concept that one operation should be safer than two is easy to accept, it may still have to be shown conclusively that primary closure of a VSD in infancy is safer than main pulmonary artery banding at that stage, with pulmonary artery reconstruction and repair of any residual ventricular septal defect to follow after a few years. 
